Related references
Note: Only part of the references are listed.Dioxin and immune regulation Emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells
Nikki B. Marshall et al.
YEAR IN IMMUNOLOGY 2 (2010)
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Joshua D. Mezrich et al.
JOURNAL OF IMMUNOLOGY (2010)
Indoleamine 2,3 Dioxygenase-Mediated Tryptophan Catabolism Regulates Accumulation of Th1/Th17 Cells in the Joint in Collagen-Induced Arthritis
Gabriel Criado et al.
ARTHRITIS AND RHEUMATISM (2009)
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Emily A. Stevens et al.
IMMUNOLOGY (2009)
Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells
Marc Veldhoen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses
Akihiro Kimura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity
Grant N. Scott et al.
JOURNAL OF IMMUNOLOGY (2009)
Langerhans Cell Maturation and Contact Hypersensitivity Are Impaired in Aryl Hydrocarbon Receptor-Null Mice
Bettina Jux et al.
JOURNAL OF IMMUNOLOGY (2009)
IDO Mediates TLR9-Driven Protection from Experimental Autoimmune Diabetes
Francesca Fallarino et al.
JOURNAL OF IMMUNOLOGY (2009)
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
Babak Baban et al.
JOURNAL OF IMMUNOLOGY (2009)
Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase
Christoph F. A. Vogel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells
Toshiaki Hara et al.
IMMUNOLOGY LETTERS (2008)
Functional characterization and gene expression analysis of CD4+CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin
Nikki B. Marshall et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi
Luigina Romani et al.
JOURNAL OF IMMUNOLOGY (2008)
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Marc Veldhoen et al.
NATURE (2008)
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Francisco J. Quintana et al.
NATURE (2008)
Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells
Akihiro Kimura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IDO-expressing regulatory dendritic cells in cancer and chronic infection
Alexey Popov et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells
Marcelo Hill et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Differential regulation of indoleamine 2,3-dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells
In Duk Jung et al.
FEBS LETTERS (2007)
Tryptophan catabolism generates autoimmune-preventive regulatory T cells
Francesca Fallarino et al.
TRANSPLANT IMMUNOLOGY (2006)
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2006)
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells
Francesca Fallarino et al.
JOURNAL OF IMMUNOLOGY (2006)
The signal transducer and activator of transcription 1α and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide:: Involvement of p38 mitogen-activated protein kinase and nuclear Factor-κB pathways, and synergistic effect of several proinflammatory cytokines
Hidetsugu Fujigaki et al.
JOURNAL OF BIOCHEMISTRY (2006)
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO
G Wingender et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite
M Platten et al.
SCIENCE (2005)
Cutting edge:: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2005)
Cutting edge:: Activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+CD25+ cells with characteristics of regulatory T cells
CJ Funatake et al.
JOURNAL OF IMMUNOLOGY (2005)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
T cell-specific disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution
S Tomita et al.
JOURNAL OF IMMUNOLOGY (2003)
Cutting edge: Induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2003)
Tryptophan and the immune response
JR Moffett et al.
IMMUNOLOGY AND CELL BIOLOGY (2003)
Tolerance, DCs and tryptophan: much ado about IDO
U Grohmann et al.
TRENDS IN IMMUNOLOGY (2003)
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
DH Munn et al.
SCIENCE (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
